Outcomes of childhood‐onset Graves' disease (GD) and suggested duration of anti‐thyroid drug (ATD) therapy have been controversial. This study aimed to determine long‐term outcomes following ATD therapy, including remission and… Click to show full abstract
Outcomes of childhood‐onset Graves' disease (GD) and suggested duration of anti‐thyroid drug (ATD) therapy have been controversial. This study aimed to determine long‐term outcomes following ATD therapy, including remission and relapse rates.
               
Click one of the above tabs to view related content.